NEW COSMO26 — Social Media in Oncology: top voices, key slides & takeaways, decoded View Full Coverage →
KOL Pulse AI · Conference Intelligence · GI Cancer
ASCO 2026 GI Virtual Attendee Network
815 accounts classified from 336 curated GI-cancer tweets at ASCO 2026 Annual Meeting (GI Cancer). Filter the entire page by GI trial, or click any KOL to view their engagement cohort.
See who amplifies whom → GI Influencer Networks
815 Identified Accounts 209 Verified US Physicians 298 Int'l Physicians 42 Countries
Top 10 GI KOLs ranked by 25×25 engagement · Click a KOL to view their engagement cohort
Free Access · KOL Pulse Intelligence

Track oncology’s top KOLs in your specialty

Create a free account, pick the tumor types you cover, and go beyond the tweet — the intelligence pharma teams use to map influence and prepare for engagement:

  • ✓Enhanced KOL profiles
  • ✓Pharma influence & potential advisory-board patterns
  • ✓2025 Open Payments financial analysis
  • ✓Social-media sentiment & trend signals
Get free access — pick your specialty
Choose the tumor types you follow. No cost, unsubscribe anytime.
Category Breakdown
Physicians by Region / Country
Network
Top Accounts

Methodology

Accounts were captured from 336 GI-cancer tweets curated at ASCO 2026 and classified into physician (US / international), researcher, pharma, institution, media, patient-advocate and general-public categories via the KOL Pulse account registry. US physicians are cross-referenced against CMS Open Payments. Top-10 KOLs are ranked by the locked 25×25 engagement formula (retweets, quotes, replies, mentions among the tumor's top voices). Trial attribution ties an account to a GI trial when it authored a tweet tagged to that trial or engaged a KOL who did. Real accounts only; no synthetic voices.